Thomas Morel

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Venues

Neurology and therapy

Rheumatology and therapy

Orphanet journal of rare diseases

Journal of neurology

KU Leuven

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KU Leuven

Belgium

Research Fellow :: Clinical Pharmacology & Pharmacotherapy

Publications

Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J Kaminski, Thomas H Brannagan
Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO. Neurology and therapy (2023)
Thomas Morel, Sophie Cleanthous, John Andrejack, Roger A Barker, Milton Biagioni, Geraldine Blavat, Bastiaan R Bloem, Babak Boroojerdi, William Brooks, Paul Burns, Stefan Cano, Casey Gallagher, Lesley Gosden, Carroll Siu, Ashley F Slagle, Natasha Ratcliffe, Karlin Schroeder
Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson's. Journal of patient-reported outcomes 7 (1) (2023)
Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J Kaminski, Thomas H Brannagan
Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO. Neurology and therapy (2023)
Antoine Regnault, Thomas Morel, Christine de la Loge, Flora Mazerolle, Henry J Kaminski, Thomas H Brannagan
Correction to: Measuring Overall Severity of Myasthenia Gravis (MG): Evidence for the Added Value of the MG Symptoms PRO. Neurology and therapy (2023)
Elena Nicod, Andrew J Lloyd, Thomas Morel, Michela Meregaglia, Sheela Upadhyaya, Amanda Whittal, Karen M Facey, Michael F Drummond
Improving Interpretation of Evidence Relating to Quality of Life in Health Technology Assessments of Rare Disease Treatments. The patient (2022)
Thomas Morel, Stefan Cano, Susan J Bartlett, Caroline Gordon, Birgit Haier, Antoine Regnault, Matthias Schneider, Christian Stach, Sophie Cleanthous
The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus. Rheumatology (Oxford, England) 61 (8) (2022)
Thomas Morel, Sophie Cleanthous, John Andrejack, Roger A Barker, Geraldine Blavat, William Brooks, Paul Burns, Stefan Cano, Casey Gallagher, Lesley Gosden, Carroll Siu, Ashley F Slagle, Kate Trenam, Babak Boroojerdi, Natasha Ratcliffe, Karlin Schroeder
Patient Experience in Early-Stage Parkinson's Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment. Neurology and therapy 11 (3) (2022)
Sophie Cleanthous, Sara Strzok, Birgit Haier, Stefan Cano, Thomas Morel
The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model. Rheumatology and therapy (2021)
Sophie Cleanthous, Ann-Christin Mork, Antoine Regnault, Stefan Cano, Henry J Kaminski, Thomas Morel
Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease. Orphanet journal of rare diseases 16 (1) (2021)
Sophie Cleanthous, Sara Strzok, Birgit Haier, Stefan Cano, Thomas Morel
Correction to: The Patient Experience of Fatigue in Systemic Lupus Erythematosus: A Conceptual Model. Rheumatology and therapy (2021)
Antoine Regnault, Babak Boroojerdi, Juliette Meunier, Massimo Bani, Thomas Morel, Stefan J Cano
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort. Journal of neurology 266 (8) (2019)
Thomas Morel, Stefan J Cano
Measuring what matters to rare disease patients - reflections on the work by the IRDiRC taskforce on patient-centered outcome measures. Orphanet journal of rare diseases 12 (1) (2017)

Thomas Morel.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Morel